EDXC: AI 评分 36/100 — AI 分析 (4月 2026)

Endexx Corporation manufactures and sells cannabidiol (CBD)-based health and wellness products, including creams, oils, and pet products. The company operates primarily through its e-commerce site, cbdunlimited.com, and other online and in-store retailers.

Key Facts: AI Score: 36/100 Sector: Healthcare

公司概况

概要：

Endexx Corporation focuses on the cannabidiol (CBD) health and wellness market, offering a range of CBD-based products for humans and pets. Operating in the specialty and generic drug manufacturing sector, the company leverages its e-commerce platform and retail partnerships to distribute CBD creams, oils, and other health and beauty products.

EDXC是做什么的？

Endexx Corporation, formerly known as CBD Unlimited, Inc., was rebranded in May 2020 and is dedicated to the manufacturing and sale of cannabidiol (CBD)-based products. Headquartered in Cave Creek, Arizona, the company targets the health and wellness market, providing a diverse range of products including CBD creams, oils, capsules, extracts, topicals, drinks, and chocolates. Endexx also caters to the pet market with specialized CBD products. The company distributes its products through its e-commerce platform, cbdunlimited.com, as well as through various online and in-store retailers. Endexx focuses on hemp-derived health and beauty care products designed to provide therapeutic relief from pain and inflammation for both humans and pets. The company aims to capitalize on the growing demand for CBD products in the health and wellness sector by offering a wide array of accessible and consumer-friendly options.

EDXC的投资论点是什么？

Endexx Corporation presents a speculative investment opportunity within the burgeoning CBD market. With a negative P/E ratio of -0.00 and a high profit margin of 1181.3%, the company's financial metrics suggest potential volatility. Key value drivers include expanding its product line and increasing its distribution network. Growth catalysts involve capitalizing on the increasing acceptance and legalization of CBD products. Potential risks include intense competition, regulatory uncertainties, and the challenges of operating on the OTC market. Investors should carefully consider these factors when evaluating EDXC.

EDXC在哪个行业运营？

Endexx Corporation operates within the rapidly expanding CBD health and wellness market. This market is characterized by increasing consumer demand for natural health solutions and a growing acceptance of CBD products. The competitive landscape includes numerous players, ranging from large pharmaceutical companies to smaller, specialized CBD manufacturers. Endexx aims to differentiate itself through its diverse product range and multi-channel distribution strategy. The industry faces ongoing regulatory challenges and evolving consumer preferences.

Drug Manufacturers - Specialty & Generic

Healthcare

EDXC有哪些增长机遇？

Expansion of Product Line: Endexx can grow by introducing new CBD-infused products targeting specific health and wellness needs. The market for specialized CBD products, such as those targeting sleep, anxiety, and pain management, is expanding rapidly. By investing in research and development to create innovative formulations, Endexx can attract new customers and increase revenue streams. This expansion could tap into a market projected to reach $20 billion by 2028.
Strategic Partnerships: Forming partnerships with established retailers and healthcare providers can significantly expand Endexx's distribution network. Collaborating with pharmacies, wellness centers, and online marketplaces can provide access to a broader customer base. These partnerships can also enhance the company's credibility and brand recognition. The timeline for establishing such partnerships is ongoing, with potential benefits realized within the next 1-2 years.
Geographic Expansion: Expanding into new geographic markets, both domestically and internationally, represents a significant growth opportunity. As CBD regulations evolve globally, Endexx can target regions with favorable regulatory environments and high consumer demand. This expansion requires careful market research and strategic planning to ensure successful market entry. The global CBD market is expected to grow substantially over the next five years, presenting a lucrative opportunity for Endexx.
E-commerce Optimization: Enhancing the user experience and functionality of cbdunlimited.com can drive increased online sales. Improving website navigation, offering personalized product recommendations, and implementing targeted marketing campaigns can attract and retain customers. Investing in e-commerce optimization can lead to higher conversion rates and increased revenue. This is an ongoing process that can yield immediate and long-term benefits.
Pet Product Innovation: Capitalizing on the growing market for CBD pet products can drive significant revenue growth. Developing new formulations and delivery methods specifically tailored to pets can attract pet owners seeking natural health solutions for their animals. This includes CBD-infused treats, oils, and topicals designed to address various pet health concerns. The pet CBD market is projected to reach $1 billion by 2027, offering a substantial opportunity for Endexx.

Market Cap: $0.00B indicates the company is a microcap stock.
P/E Ratio: -0.00 reflecting that the company is currently not profitable.
Profit Margin: 1181.3% suggests potential profitability if revenue increases.
Gross Margin: -96.0% indicates significant cost of goods sold relative to revenue.
Beta: -0.81 suggests the stock is less volatile than the market.

EDXC提供哪些产品和服务？

Manufactures CBD-based creams for pain relief.
Produces CBD oils for general wellness.
Creates CBD capsules for easy consumption.
Offers CBD extracts for concentrated doses.
Develops CBD topicals for localized application.
Sells CBD-infused drinks and chocolates.
Provides CBD products specifically for pets.
Distributes hemp-derived health and beauty care products.

EDXC如何赚钱？

Manufacturing and selling CBD-based products.
Distribution through e-commerce platform cbdunlimited.com.
Partnerships with online and in-store retailers.
Focus on therapeutic relief of pain and inflammation for humans and pets.

Individuals seeking natural health and wellness solutions.
Pet owners looking for CBD products for their pets.
Retailers offering CBD products to their customers.
Consumers interested in alternative pain relief methods.

Established e-commerce platform (cbdunlimited.com).
Diverse range of CBD products for humans and pets.
Focus on hemp-derived health and beauty care products.
Distribution network through online and in-store retailers.

什么因素可能推动EDXC股价上涨？

Upcoming: Potential changes in CBD regulations at the state or federal level could significantly impact the company's market access and growth prospects.
Ongoing: Increasing consumer awareness and acceptance of CBD products may drive higher demand and sales for Endexx's product line.
Ongoing: Expansion of the company's distribution network through strategic partnerships with retailers and healthcare providers.
Upcoming: Launch of new CBD-infused products targeting specific health and wellness needs.
Ongoing: Optimization of the company's e-commerce platform to improve user experience and drive online sales.

EDXC的主要风险是什么？

Potential: Intense competition from larger CBD companies with greater resources and brand recognition.
Potential: Evolving and uncertain regulatory landscape could restrict the sale or marketing of CBD products.
Potential: Negative publicity or health concerns related to CBD products could damage the company's reputation and sales.
Ongoing: Limited financial resources and small company size may hinder the company's ability to compete effectively.
Ongoing: Reliance on a single e-commerce platform and limited retail partnerships increases the company's vulnerability to market changes.

EDXC的核心优势是什么？

Diverse product range including creams, oils, capsules, and pet products.
Established e-commerce platform (cbdunlimited.com).
Focus on the growing CBD health and wellness market.
Hemp-derived health and beauty care products.

EDXC的劣势是什么？

Small company size with only 10 employees.
Negative gross margin (-96.0%).
Limited brand recognition compared to larger competitors.
Reliance on a single e-commerce platform and limited retail partnerships.

EDXC有哪些机遇？

Expansion into new geographic markets.
Development of new CBD-infused products.
Strategic partnerships with retailers and healthcare providers.
Capitalizing on the growing market for CBD pet products.

EDXC面临哪些威胁？

Intense competition from larger CBD companies.
Evolving and uncertain regulatory landscape.
Changing consumer preferences and market trends.
Potential negative publicity or health concerns related to CBD products.

EDXC的竞争对手是谁？

BioNet Pharmacies, Inc. — Focuses on pharmaceutical products and distribution. — (BINP)
BMC Stock Holdings, Inc. — Operates in the building materials and construction sector. — (BMCS)
BMMJ Holdings, Inc. — Engages in cannabis-related investments and operations. — (BMMJ)
China Advanced Construction Materials Group, Inc. — Specializes in construction materials and technologies. — (CATV)
Cydyax BioScience, Inc. — Focuses on biotechnology and pharmaceutical development. — (CYDX)

Key Metrics

MoonshotScore: 36/100

Company Profile

CEO: Todd A. Davis
Headquarters: Cave Creek, US
Employees: 10
Founded: 2001

AI Insight

AI analysis pending for EDXC

OTC Tier: OTC Other
Disclosure Status: Unknown

常见问题

What does Endexx Corporation do?

Endexx Corporation manufactures and sells a variety of cannabidiol (CBD)-based products aimed at the health and wellness market. These products include CBD creams, oils, capsules, extracts, topicals, drinks, chocolates, and pet products. The company distributes these products through its e-commerce platform, cbdunlimited.com, and through partnerships with online and in-store retailers. Endexx focuses on providing hemp-derived health and beauty care products designed to offer therapeutic relief from pain and inflammation for both humans and pets, positioning itself as a provider of accessible and consumer-friendly CBD solutions.

What do analysts say about EDXC stock?

As of 2026-03-16, there is no readily available analyst coverage for Endexx Corporation (EDXC). Given its OTC listing and microcap status, the stock may not be widely followed by analysts. Investors should conduct their own thorough research and due diligence before considering an investment in EDXC, paying close attention to its financial performance, market position, and risk factors. The absence of analyst coverage highlights the speculative nature of this investment.

What are the main risks for EDXC?

Endexx Corporation faces several key risks, including intense competition in the crowded CBD market, evolving and uncertain regulations regarding CBD products, and potential negative publicity related to CBD's safety and efficacy. As an OTC-listed company, EDXC also carries risks associated with limited liquidity and financial disclosure. The company's small size and reliance on a single e-commerce platform make it vulnerable to market changes and competitive pressures. Investors should carefully consider these risks before investing in EDXC.